AIFG Consultants’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,136
Closed -$425K 51
2024
Q4
$425K Sell
18,136
-6,378
-26% -$151K 0.69% 34
2024
Q3
$590K Sell
24,514
-5,584
-19% -$133K 0.45% 27
2024
Q2
$702K Buy
+30,098
New +$701K 0.52% 23
2023
Q2
Sell
-11,492
Closed -$269K 41
2023
Q1
$269K Buy
11,492
+1,120
+11% +$26K 0.23% 33
2022
Q4
$239K Buy
+10,372
New +$237K 0.23% 31

Other funds holding IBD

AIFG Consultants's IBD Position: Q1 2025 in Review

AIFG Consultants sold out of Inspire Corporate Bond ETF (IBD) in Q1 2025, closing a stake of 18,136 shares — an estimated $425K sold.

AIFG Consultants first reported a position in IBD in Q4 2022 and held it in 5 quarters. The position peaked at $702K in Q2 2024. 92 funds tracked by Wall St. Rank hold IBD as of Q1 2025.

  • AIFG Consultants reported no remaining Inspire Corporate Bond ETF position as of Q1 2025 after selling out during the quarter.
  • AIFG Consultants sold 18,136 Inspire Corporate Bond ETF shares in Q1 2025, an estimated $425K.
  • AIFG Consultants first reported a position in Inspire Corporate Bond ETF in Q4 2022 and held it in 5 quarters.
  • AIFG Consultants's Inspire Corporate Bond ETF position peaked at $702K in Q2 2024.
  • 92 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2025.

Based on AIFG Consultants's 13F filing for Q1 2025, filed 23 Apr 2025.